BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health an… Read more
BioHarvest Sciences Inc. Common Stock (BHST) - Total Assets
Latest total assets as of September 2025: $35.19 Million USD
Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) holds total assets worth $35.19 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioHarvest Sciences Inc. Common Stock - Total Assets Trend (2020–2024)
This chart illustrates how BioHarvest Sciences Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioHarvest Sciences Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
BioHarvest Sciences Inc. Common Stock's total assets of $35.19 Million consist of 31.4% current assets and 68.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.6% |
| Accounts Receivable | $1.12 Million | 4.5% |
| Inventory | $3.65 Million | 14.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioHarvest Sciences Inc. Common Stock's current assets represent 31.4% of total assets in 2024, a decrease from 42.2% in 2020.
- Cash Position: Cash and equivalents constituted 9.6% of total assets in 2024, down from 33.6% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 14.6% of total assets.
BioHarvest Sciences Inc. Common Stock Competitors by Total Assets
Key competitors of BioHarvest Sciences Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
BioHarvest Sciences Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - BioHarvest Sciences Inc. Common Stock generates 1.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioHarvest Sciences Inc. Common Stock is currently not profitable relative to its asset base.
BioHarvest Sciences Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.35 | 0.80 | 0.32 |
| Quick Ratio | 1.02 | 0.48 | 0.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.65 Million | $ -1.95 Million | $ -9.87 Million |
BioHarvest Sciences Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between BioHarvest Sciences Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.37 |
| Latest Market Cap to Assets Ratio | 3.83 |
| Asset Growth Rate (YoY) | 66.7% |
| Total Assets | $25.00 Million |
| Market Capitalization | $95.65 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values BioHarvest Sciences Inc. Common Stock's assets at a significant premium ( 3.83x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: BioHarvest Sciences Inc. Common Stock's assets grew by 66.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BioHarvest Sciences Inc. Common Stock (2020–2024)
The table below shows the annual total assets of BioHarvest Sciences Inc. Common Stock from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $25.00 Million | +66.65% |
| 2023-12-31 | $15.00 Million | +59.71% |
| 2022-12-31 | $9.39 Million | -7.98% |
| 2021-12-31 | $10.21 Million | +92.46% |
| 2020-12-31 | $5.30 Million | -- |